Transient kinetics reveal the mechanism of competitive inhibition of the neutral amino acid ASCT2

被引:0
|
作者
Dong, Yang [1 ]
Wang, Jiali [1 ]
Grewer, Christof [1 ]
机构
[1] Binghamton Univ, Dept Chem, Binghamton, NY 13902 USA
基金
美国国家卫生研究院;
关键词
MOLECULAR-DYNAMICS; TRANSPORTER; GLUTAMATE; SUBSTRATE; PHOTOLYSIS; BINDING; ELECTROSTATICS; EXPRESSION; EXCHANGER; CURRENTS;
D O I
10.1016/j.jbc.2024.107382
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
ASCT2 (alanine serine cysteine transporter 2), a member of the solute carrier 1 family, mediates Na+-dependent exchange of small neutral amino acids across cell membranes. ASCT2 was shown to be highly expressed in tumor cells, making it a promising target for anticancer therapies. In this study, we explored the binding mechanism of the high-affinity competitive inhibitor L- cis hydroxyproline biphenyl ester (Lc-BPE) with ASCT2, using electrophysiological and rapid kinetic methods. Our investigations reveal that Lc-BPE binding requires one or two Na+ ions initially bound to the apo-transporter with high affinity, with Na1 site occupancy being more critical for inhibitor binding. In contrast to the amino acid substrate bound form, the fi nal, third Na+ ion cannot bind, due to distortion of its binding site (Na2), thus preventing the formation of a translocation-competent complex. Based on the rapid kinetic analysis, the application of Lc-BPE generated outward transient currents, indicating that despite its net neutral nature, the binding of Lc-BPE in ASCT2 is weakly electrogenic, most likely because of asymmetric charge distribution within the amino acid moiety of the inhibitor. The preincubation with Lc-BPE also led to a decrease of the turnover rate of substrate exchange and a delay in the activation of substrate-induced anion current, indicating relatively slow Lc-BPE dissociation kinetics. Overall, our results provide new insight into the mechanism of binding of a prototypical competitive inhibitor to the ASCT transporters.
引用
收藏
页数:15
相关论文
共 50 条
  • [41] Expression of amino acid transporters (LAT1, ASCT2 and xCT) as clinical significance in hepatocellular carcinoma
    Namikawa, Masashi
    Kakizaki, Satoru
    Kaira, Kyoichi
    Tojima, Hiroki
    Yamazaki, Yuichi
    Horiguchi, Norio
    Sato, Ken
    Oriuchi, Noboru
    Tominaga, Hideyuki
    Sunose, Yutaka
    Nagamori, Shushi
    Kanai, Yoshikatsu
    Oyama, Tetsunari
    Takeyoshi, Izumi
    Yamada, Masanobu
    HEPATOLOGY RESEARCH, 2015, 45 (09) : 1014 - 1022
  • [42] Differential levels of amino acid transporters System L and ASCT2, and the mTOR protein in placenta of preeclampsia and IUGR
    Yukiyo Aiko
    David J Askew
    Satoshi Aramaki
    Mai Myoga
    Chiharu Tomonaga
    Toru Hachisuga
    Reiko Suga
    Toshihiro Kawamoto
    Mayumi Tsuji
    Eiji Shibata
    BMC Pregnancy and Childbirth, 14
  • [43] The serine/threonine kinases SGK1, 3 and PKB stimulate the amino acid transporter ASCT2
    Palmada, M
    Speil, A
    Jeyaraj, S
    Böhmer, C
    Lang, F
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2005, 331 (01) : 272 - 277
  • [44] Differential levels of amino acid transporters System L and ASCT2, and the mTOR protein in placenta of preeclampsia and IUGR
    Aiko, Yukiyo
    Askew, David J.
    Aramaki, Satoshi
    Myoga, Mai
    Tomonaga, Chiharu
    Hachisuga, Toru
    Suga, Reiko
    Kawamoto, Toshihiro
    Tsuji, Mayumi
    Shibata, Eiji
    BMC PREGNANCY AND CHILDBIRTH, 2014, 14
  • [45] Discovery and Synthesis of Hydroxy-<sc>l</sc>-Proline Blockers of the Neutral Amino Acid Transporters SLC1A4 (ASCT1) and SLC1A5 (ASCT2)
    Lyda, Brent R.
    Leary, Gregory P.
    Farnsworth, Jill
    Seaver, Benjamin
    Silvius, Derek
    Kavanaugh, Michael P.
    Esslinger, C. Sean
    Natale, Nicholas R.
    MOLECULES, 2024, 29 (10):
  • [46] ASC AMINO ACID TRANSPORTER 2 (ASCT2) AS A NOVEL PROGNOSTIC MARKER IN NON-SMALL-CELL LUNG CANCER
    Shimizu, K.
    Kaira, K.
    Tomizawa, Y.
    Sunaga, N.
    Kawashima, O.
    Oriuchi, N.
    Kana, Y.
    Yamada, M.
    Oyama, T.
    Takeyoshi, I.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : E49 - E49
  • [47] Inactivation of the glutamine/amino acid transporter ASCT2 by 1,2,3-dithiazoles: proteoliposomes as a tool to gain insights in the molecular mechanism of action and of antitumor activity
    Oppedisano, Francesca
    Catto, Marco
    Koutentis, Panayiotis A.
    Nicolotti, Orazio
    Pochini, Lorena
    Koyioni, Maria
    Introcaso, Antonellina
    Michaelidou, Sophia S.
    Carotti, Angelo
    Indiveri, Cesare
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2012, 265 (01) : 93 - 102
  • [48] Evaluation of anti-ASC amino acid transporter 2 (ASCT2) antibody as a novel therapeutic antibody for gastric cancer
    Hosomi, Kenta
    Ishii, Toshihiko
    Takahashi, Takeshi
    Nakamura, Kazuyasu
    CANCER SCIENCE, 2018, 109 : 1138 - 1138
  • [49] Expression of the Sodium-neutral amino acid exchanger ASCT2 along the small intestinal crypt-villus axis in the formula-fed neonatal pig
    Yang, Chengbo
    Fan, Ming
    FASEB JOURNAL, 2008, 22
  • [50] The establishment and evaluation of anti-ASC amino acid transporter 2 (ASCT2) antibody as a novel therapeutic antibody for gastric cancer
    Sasakawa, Aya
    Hosomi, Kenta
    Ishii, Toshihiko
    Ando, Hiroshi
    Suzuki, Masayo
    Imaizumi, Minami
    Zou, Jian
    Kasai, Noriyuki
    Yamano, Kazuya
    Nakamura, Kazuyasu
    Nakai, Ryuichiro
    MOLECULAR CANCER THERAPEUTICS, 2018, 17 (01)